Immunomedics, Inc. total revenue, net income and dynamics of changes in Euro today
Immunomedics, Inc. current income and income for the latest reporting periods. Net revenue Immunomedics, Inc. is now 295 000 €. Information about net revenue is taken from open sources. These are the main financial indicators of Immunomedics, Inc.. Chart of online financial report of Immunomedics, Inc.. Immunomedics, Inc. financial report on the graph shows the dynamics of assets. A graph of the value of all Immunomedics, Inc. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2019
273 951.75 €
-
-92 500 969.20 €
-
30/09/2019
0 €
-
-87 564 265.80 €
-
30/06/2019
0 €
-
-70 533 753.45 €
-
31/03/2019
0 €
-
-81 105 505.05 €
-
Show:
to
Immunomedics, Inc. financial report charts
Dates of Immunomedics, Inc. finance reports: 31/03/2019, 30/09/2019, 31/12/2019. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of Immunomedics, Inc. for today is 31/12/2019. Gross profit Immunomedics, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Immunomedics, Inc. is -74 523 000 €
Immunomedics, Inc. quarterly report dates
Cost of revenue Immunomedics, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Immunomedics, Inc. is 74 818 000 € Total revenue Immunomedics, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Immunomedics, Inc. is 295 000 € Operating income Immunomedics, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Immunomedics, Inc. is -91 251 000 €
Net income Immunomedics, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Immunomedics, Inc. is -99 608 000 € Current assets Immunomedics, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Immunomedics, Inc. is 638 704 000 € Total assets Immunomedics, Inc. refers to the total amount of assets owned by a person or entity. Total assets Immunomedics, Inc. is 671 722 000 €
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-69 205 783.95 €
-64 037 846.70 €
-49 146 943.95 €
-54 021 427.80 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
69 479 735.70 €
64 037 846.70 €
49 146 943.95 €
54 021 427.80 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
273 951.75 €
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-84 740 241.15 €
-80 579 889.15 €
-62 375 563.20 €
-73 965 115.20 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-92 500 969.20 €
-87 564 265.80 €
-70 533 753.45 €
-81 105 505.05 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
236 685 954.15 €
236 685 954.15 €
236 685 954.15 €
54 021 427.80 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
85 014 192.90 €
80 579 889.15 €
62 375 563.20 €
73 965 115.20 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
593 132 469.60 €
351 101 206.05 €
410 703 820.35 €
416 831 053.05 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
623 794 635.30 €
382 353 064.50 €
443 602 175.25 €
449 999 645.10 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
565 202 392.20 €
338 635 937.10 €
397 377 692.85 €
406 688 337.75 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
66 638 066.70 €
53 910 918.45 €
41 373 214.80 €
52 822 540.65 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
375 631 495.80 €
360 663 515.10 €
337 216 031.25 €
281 167 360.50 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
60.22 %
94.33 %
76.02 %
62.48 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
249 120 577.65 €
22 618 199.40 €
107 286 005.85 €
169 732 146.45 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-86 052 423.60 €
-58 138 133.25 €
-11 604 410.40 €
-50 775 796.05 €
Last revenue report of Immunomedics, Inc. was 31/12/2019. According to last financial report total revenue in Immunomedics, Inc. was 273 951.75 Euro and changed by 0% since last year. Net income in Immunomedics, Inc. was -92 500 969.20 € in last quartal, net income changes to 0%.
Current cash Immunomedics, Inc. - the sum of all of the cash a company has on the date of report. Current cash Immunomedics, Inc. is 608 628 000 € Current debt Immunomedics, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Immunomedics, Inc. is 71 758 000 € Total debt Immunomedics, Inc. is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt Immunomedics, Inc. is 404 492 000 €
Immunomedics, Inc. stocks data
IM3.F stock price
Immunomedics, Inc. stock price today, IM3.F stock quote.
